Topline Capital Management LLC Acquires New Shares in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Topline Capital Management LLC purchased a new position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,327,164 shares of the company's stock, valued at approximately $16,660,000. KORU Medical Systems accounts for 3.1% of Topline Capital Management LLC's investment portfolio, making the stock its 11th largest holding. Topline Capital Management LLC owned 9.44% of KORU Medical Systems as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of KRMD. JPMorgan Chase & Co. increased its stake in shares of KORU Medical Systems by 2,770.7% in the fourth quarter. JPMorgan Chase & Co. now owns 17,712 shares of the company's stock valued at $68,000 after buying an additional 17,095 shares during the period. Virtu Financial LLC bought a new position in KORU Medical Systems during the 4th quarter worth approximately $73,000. Y Intercept Hong Kong Ltd acquired a new position in shares of KORU Medical Systems in the 4th quarter worth approximately $104,000. Raymond James Financial Inc. acquired a new position in KORU Medical Systems in the fourth quarter valued at $118,000. Finally, HighTower Advisors LLC grew its position in shares of KORU Medical Systems by 13.0% during the 4th quarter. HighTower Advisors LLC now owns 43,400 shares of the company's stock worth $167,000 after buying an additional 5,000 shares during the period. 58.60% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. B. Riley raised KORU Medical Systems to a "strong-buy" rating in a research note on Thursday, March 13th. Piper Sandler reiterated a "neutral" rating and issued a $4.50 target price on shares of KORU Medical Systems in a report on Friday, February 14th. Craig Hallum raised their price objective on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, January 17th. Finally, Lake Street Capital boosted their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a "buy" rating in a research report on Tuesday, January 14th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $4.70.

KORU Medical Systems Stock Performance

Shares of KRMD stock traded up $0.19 during trading hours on Monday, hitting $2.66. 116,896 shares of the company were exchanged, compared to its average volume of 140,335. The firm has a fifty day simple moving average of $2.79 and a 200 day simple moving average of $3.38. KORU Medical Systems, Inc. has a 52-week low of $1.86 and a 52-week high of $5.05. The stock has a market capitalization of $122.25 million, a price-to-earnings ratio of -10.64 and a beta of 0.87. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.